Influence of the pandemic dissemination of COVID-19 on radiotherapy practice: A flash survey in Germany, Austria and Switzerland.

Influence of the pandemic dissemination of COVID-19 on radiotherapy practice: A flash survey in Germany, Austria and Switzerland.

Publication date: Apr 03, 2020

The COVID-19 pandemic has already changed our globalised world and its long-term impact is not yet known. It is apparent that businesses and institutions are increasingly affected. COVID-19 discussions often focus on intensive care units in hospitals. However, COVID-19 also effects life-saving and -prolonging radiotherapy for patients suffering from cancer.

We have conducted a structured online survey among medical physicists in Germany, Austria and Switzerland from March 23rd to 26th 2020. In total 154 responses (82 completed, 72 partially completed) were analysed in the context of the COVID-19 dissemination.

72.4% of the respondent’s state that their processes are affected due to COVID-19, while the top three answers are longer processing times (54.2%), patient no-shows (42.5%) and staff reduction (36.7%). 75.8% expect further unavailability of their personnel in the upcoming weeks. All participants have already taken several measures, especially providing information for patients at the entrance (89.6%) or over the phone (73.6%), restricting access for accompanying persons (77.4%) and providing disinfectant at the entrance (72.6%).

The results presented in this article aim to support business continuity and risk management for radiotherapy centres to prepare for future challenges. The results show that most radiotherapy centres has implemented initial contingency measures, applying them pragmatically. The main problem however remains, that is the high risk of infection both for patients and medical personnel along with the associated risk of temporarily loss of personnel and ordered closure of business.

Open Access PDF

Concepts Keywords
Austria Radiation therapy
Business Continuity Radiobiology
Cancer Medical physics
Disinfectant Global health
Germany Articles
Infection Radiotherapy
Intensive Care Units High risk infection
Pandemic Radioactivity
Radiotherapy Pandemic
Risk Management Flash


Type Source Name
disease MESH suffering
disease MESH cancer
drug DRUGBANK Etoperidone
disease MESH infection
disease MESH pneumonia
disease MESH Emergency
drug DRUGBANK Cysteamine
drug DRUGBANK Amber
disease MESH community
drug DRUGBANK Bean
drug DRUGBANK Trestolone
drug DRUGBANK Tricyclazole
disease MESH sitting
disease MESH men
drug DRUGBANK Spinosad
drug DRUGBANK Coenzyme M
drug DRUGBANK Diethylstilbestrol

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *